Several hedge funds and institutional investors have adjusted their holdings in Becton, Dickinson and Company (BDX). Jennison Associates LLC increased its stake by 4.9%, owning 402,350 shares valued at $99.56 million after adding 18,786 shares. Norden Group LLC raised its stake dramatically by 2,086.7%, now holding 51,934 shares worth $12.85 million after buying 49,559 additional shares. Franklin Street Advisors Inc. NC entered a new position valued at $11.998 million. Avity Investment Management Inc. increased its stake by 3.5%, owning 162,687 shares worth $40.26 million after acquiring 5,527 shares. Lastly, Caden Capital Partners LP boosted its stake by 26.7% in the last quarter, now holding 83,417 shares worth $20.34 million. In total, 86.97% of BDX shares are held by these investors.
Analyst Ratings
Recent analyst reports on BDX are positive. Evercore ISI raised its target price from $286 to $290 and rated the stock as “outperform.” StockNews.com upgraded it from “hold” to “buy.” Stifel Nicolaus increased their target from $270 to $280 with a “buy” rating. Raymond James lowered their target from $275 to $270 but maintained an “outperform” rating. Citigroup upgraded BDX from “neutral” to “buy,” increasing their target from $255 to $275. Overall, nine analysts rated BDX as a “buy,” giving it a consensus rating of “Buy” with an average target price of $282.63.
See Our Latest Report on Becton, Dickinson and Company
Becton, Dickinson and Company Performance
As of Thursday, BDX opened at $239.76. It has a quick ratio of 1.36, a current ratio of 1.85, and a debt-to-equity ratio of 0.70. The company is valued at $69.29 billion with a P/E ratio of 52.81. BDX’s 52-week low is $218.75, and its high is $269.52. The stock’s 50-day and 200-day moving averages are $236.55 and $235.57, respectively. In the most recent quarter, BDX reported earnings of $3.50 per share, beating estimates of $3.31. Revenue was $4.99 billion, slightly below expectations of $5.08 billion. The company expects to earn 13.1 EPS this year.
Dividend Announcement
BDX recently declared a quarterly dividend of $0.95 per share, paid on September 30th. The dividend yield stands at 1.58%, with an annual payout of $3.80 and a payout ratio of 83.70%.
Becton, Dickinson and Company Overview
Becton, Dickinson and Company produces medical supplies, devices, and diagnostic products for healthcare institutions and the public globally, operating in three segments: BD Medical, BD Life Sciences, and BD Interventional.
Explore More
- Five Stocks Better Than Becton, Dickinson and Company
- Understanding the Shanghai Stock Exchange Composite Index
- S&P 500 Resistance: Top 3 Stocks for Upside
- Rallying Natural Gas Prices: Benefiting Stocks
- Nikes Earnings Drop: A Buying Opportunity
- Russell 2000 Index: Profitable Trading Tips
- Microsofts Targeted Upside: Dont Miss Out
Get Daily News & Ratings for Becton Dickinson and Company – Enter your email to receive a daily summary of news and ratings for Becton, Dickinson and Company with MarketBeat.com’s FREE daily newsletter.
`
